|
|
|
|
| Advertisement |
 |
|
|
| UK |
 |
|
A Tale of Two Pricing Schemes |
The UK is moving closer to aligning its two approaches to regulating drug pricing — the voluntary PPRS and statutory price cuts — but the headaches are likely to continue, writes Leela Barham
/Read more/ |
|
|
|
ADVERTISEMENT
|
| Industry update |
| //Santhera Pharmaceuticals (Liestal, Switzerland) has appointed Kristina Timdahl as Chief Medical Officer and Head of Development, effective January 2017, to replace Nick Coppard who will retire.//Prothena Corporation (Dublin, Ireland) appointed Gene Kinney as President and Chief Executive Officer of Prothena. Dr. Kinney has also been appointed to Prothena's Board of Directors. //Cytovation AS (Bergen, Norway) appointed Raj Airey as Venture Developer and Federico Grego as Strategic Counsel.//Nouscom (Basel, Switzerland) announced the appointment of Dr Marina Udier Blagovic as Chief Operating Officer.// |
|
|
|
|
|
| |
|
|
